Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.

Yanagawa N, Leduc C, Kohler D, Saieg MA, John T, Sykes J, Yoshimoto M, Pintilie M, Squire J, Shepherd FA, Tsao MS.

J Thorac Oncol. 2012 Oct;7(10):1513-21.

2.

Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.

Meng D, Yuan M, Li X, Chen L, Yang J, Zhao X, Ma W, Xin J.

Lung Cancer. 2013 Jul;81(1):1-10. doi: 10.1016/j.lungcan.2013.03.019. Epub 2013 Apr 19. Review.

PMID:
23608713
3.

[Non-small cell lung cancer. Subtyping and predictive molecular marker investigations in cytology].

Savic S, Bihl MP, Bubendorf L.

Pathologe. 2012 Jul;33(4):301-7. doi: 10.1007/s00292-012-1577-9. Review. German.

PMID:
22711372
4.

Do all lung adenocarcinomas follow a stepwise progression?

Yatabe Y, Borczuk AC, Powell CA.

Lung Cancer. 2011 Oct;74(1):7-11. doi: 10.1016/j.lungcan.2011.05.021. Epub 2011 Jun 25. Review.

5.

MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis.

Dimou A, Non L, Chae YK, Tester WJ, Syrigos KN.

PLoS One. 2014 Sep 18;9(9):e107677. doi: 10.1371/journal.pone.0107677. eCollection 2014. Review.

6.

[Research progress of the relationship between tumor suppressor gene 
 PTEN and non-small cell lung cancer].

Li Y, Wang H.

Zhongguo Fei Ai Za Zhi. 2014 Mar;17(3):260-4. doi: 10.3779/j.issn.1009-3419.2014.03.13. Review. Chinese. No abstract available.

7.

Phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as therapeutic targets in breast cancer.

Dirican E, Akkiprik M.

Tumour Biol. 2017 Mar;39(3):1010428317695529. doi: 10.1177/1010428317695529. Review.

PMID:
28351303
8.

The prognostic value of phosphatase and tensin homolog negativity in breast cancer: A systematic review and meta-analysis of 32 studies with 4393 patients.

Yang ZY, Yu YY, Yuan JQ, Shen WX, Zheng DY, Chen JZ, Mao C, Tang JL.

Crit Rev Oncol Hematol. 2016 May;101:40-9. doi: 10.1016/j.critrevonc.2016.01.013. Epub 2016 Jan 18. Review.

PMID:
26951995
9.

Genomic Rearrangements of PTEN in Prostate Cancer.

Phin S, Moore MW, Cotter PD.

Front Oncol. 2013 Sep 17;3:240. doi: 10.3389/fonc.2013.00240. Review.

10.

Functions and Regulation of the PTEN Gene in Colorectal Cancer.

Molinari F, Frattini M.

Front Oncol. 2014 Jan 16;3:326. doi: 10.3389/fonc.2013.00326. eCollection 2013. Review.

11.

Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review.

Borazanci E, Millis SZ, Korn R, Han H, Whatcott CJ, Gatalica Z, Barrett MT, Cridebring D, Von Hoff DD.

World J Gastrointest Oncol. 2015 Sep 15;7(9):132-40. doi: 10.4251/wjgo.v7.i9.132. Review.

12.

Prognostic factors in resected lung carcinomas.

Kerr KM, Nicolson MC.

EJC Suppl. 2013 Sep;11(2):137-49. doi: 10.1016/j.ejcsup.2013.07.023. Review. No abstract available.

Supplemental Content

Support Center